Dmitry Evseev

6PUBLICATIONS
134CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 14, 2026
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Paul G Kemps, Jennifer L Picarsic, Sébastien Héritier

|Feb 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Jean Donadieu, Dmitry Evseev, Francesco Pegoraro

|May 22, 2023
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.

Dmitry Evseev, Daria Osipova, Irina Kalinina

|Apr 21, 2022
Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia.

Olga Goronkova, Galina Novichkova, Tatiana Salimova

|Nov 02, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Paul G Kemps, Jennifer Picarsic, Benjamin H Durham

|Aug 12, 2021
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA.

Dmitry Evseev, Irina Kalinina, Elena Raykina

Pageof 1

Frequent Collaborators

3 joint publications

Michael Maschan

3 joint publications

Daria S Osipova

3 joint publications

Jean-François Emile

3 joint publications

Jean Donadieu